Transplantation and engraftment of liver sinusoidal endothelial cells (LSECs) capable of producing FVIII provides the most natural pathway for the cure of hemophilia A. Such a cell based therapy for hemophilia A offers the potential of a life-long cure if a number of hurdles can be overcome. This evidence concerns the gene F8 and hemophilia A.